These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19421707)

  • 21. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Braggion G; Chinaglia M; Roncon L
    Cardiovasc Revasc Med; 2010; 11(1):29-33. PubMed ID: 20129358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
    Tobis JM; Charles A; Silberstein SD; Sorensen S; Maini B; Horwitz PA; Gurley JC
    J Am Coll Cardiol; 2017 Dec; 70(22):2766-2774. PubMed ID: 29191325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A meta-analysis of case-control studies of the association of migraine and patent foramen ovale.
    Takagi H; Umemoto T;
    J Cardiol; 2016 Jun; 67(6):493-503. PubMed ID: 26527111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PFO and Migraine: Is There a Role for Closure?
    Rayhill M; Burch R
    Curr Neurol Neurosci Rep; 2017 Mar; 17(3):20. PubMed ID: 28283958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
    Manolis AS
    Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Migraine and patent foramen ovale: exploring the association and a possible treatment option.
    Hasan MY
    J Pak Med Assoc; 2008 Aug; 58(8):453-5. PubMed ID: 18822645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Migraine with aura and persistent foramen ovale.
    Wilmshurst PT
    Eye (Lond); 2018 Feb; 32(2):184-188. PubMed ID: 29219954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of migraine after patent foramen ovale percutaneous closure in patients with subclinical brain lesions: a case-control study.
    Vigna C; Marchese N; Inchingolo V; Giannatempo GM; Pacilli MA; Di Viesti P; Impagliatelli M; Natali R; Russo A; Fanelli R; Loperfido F
    JACC Cardiovasc Interv; 2009 Feb; 2(2):107-13. PubMed ID: 19463410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient sulcal hyperintensities on fluid-attenuated inversion recovery in migraine with aura: transient sulcal hyperintensities in migraine.
    Kang KW; Kim JT; Chang J; Choi WH; Lim D; Bang DH; Choi YJ
    Headache; 2012 Oct; 52(9):1430-3. PubMed ID: 22849294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basilar artery fenestration in a woman with basilar-type migraine.
    Morelli N; Gori S; Mancuso M; Murri L
    Neurol Sci; 2007 Apr; 28(2):116-7. PubMed ID: 17464479
    [No Abstract]   [Full Text] [Related]  

  • 31. Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure?
    Rigatelli G; Dell'Avvocata F; Giordan M; Braggion G; Aggio S; Chinaglia M; Roncon L; Cardaioli P; Chen JP
    J Interv Cardiol; 2009 Aug; 22(4):398-403. PubMed ID: 19515082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism.
    Rigatelli G; Dell'Avvocata F; Ronco F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Rigatelli G; Chen JP
    JACC Cardiovasc Interv; 2010 Mar; 3(3):282-7. PubMed ID: 20298985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basilar-type migraine responsive to lamotrigine: three case reports.
    d'Onofrio F; Cologno D; Petretta V; Casucci G; Bussone G
    Neurol Sci; 2007 May; 28 Suppl 2():S239-41. PubMed ID: 17508181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Migraine and patent foramen ovale: the secret in the bubbles?
    Sacco S; Carolei A
    Headache; 2011 Jan; 51(1):165-7. PubMed ID: 20946435
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt.
    Biasco L; Infantino V; Orzan F; Vicentini S; Rovera C; Longo G; Chinaglia A; Belli R; Allais G; Gaita F
    J Cardiol; 2014 Nov; 64(5):390-4. PubMed ID: 24713153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of patent foramen ovale in migraine with aura.
    Ferrarini G; Malferrari G; Zucco R; Gaddi O; Norina M; Pini LA
    J Headache Pain; 2005 Apr; 6(2):71-6. PubMed ID: 16362645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indications, techniques and results of percutaneous patent foramen ovale closure.
    Spies C; Hijazi ZM
    Minerva Cardioangiol; 2012 Feb; 60(1):111-23. PubMed ID: 22322579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sporadic hemiplegic migraine and CREST syndrome.
    Grecco MP; Pieroni M; Otero M; Ferreiro JL; Figuerola Mde L
    J Headache Pain; 2010 Apr; 11(2):171-3. PubMed ID: 20130953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion MRI during migraine with aura attack associated with diagnostic microbubbles injection in subjects with large PFO.
    Dinia L; Roccatagliata L; Bonzano L; Finocchi C; Del Sette M
    Headache; 2007; 47(10):1455-6. PubMed ID: 18052957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case report of sporadic hemiplegic migraine associated cerebral hypoperfusion: comparison of arterial spin labeling and dynamic susceptibility contrast perfusion MR imaging.
    Kim S; Kang M; Choi S
    Eur J Pediatr; 2016 Feb; 175(2):295-8. PubMed ID: 26250760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.